G1 Therapeutics Inc
SWB:G1H
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
G1 Therapeutics Inc
SWB:G1H
|
US |
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
B
|
Berkshire Hathaway Inc
DUS:BRYN
|
US |
|
BRP Inc
NASDAQ:DOO
|
CA |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is G1H's stock price target?
Not Available
G1H does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for G1 Therapeutics Inc?
Projected CAGR
10%
Over the last 8 years, the compound annual growth rate for Revenue has been 88%. The projected CAGR for the next 3 years is 10%.